Low-FODMAP Diet and Probiotics: Effects on Gut, Behavior, and Microbiota in Children With Autism Spectrum Disorder
NCT07086157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2025-07-25
Summary
The goal of this clinical trial was to evaluate whether a low-FODMAP diet and probiotic supplements could reduce gastrointestinal (GI) symptoms and behavior problems in children with autism spectrum disorder (ASD) who also experienced GI issues. The main questions it aimed to answer were:
Did a low-FODMAP diet and/or probiotics improve GI symptoms such as constipation, diarrhea, and abdominal pain?
Did these interventions help reduce behavior problems such as irritability, lethargy, stereotypy, hyperactivity, and speech disorder ?
Researchers compared two groups:
1. Children who received a daily probiotic supplement containing 4 strains for 4 weeks
2. Children who received both the probiotic supplement and followed a low-FODMAP diet
This comparison aimed to determine whether the combination of diet and probiotics had greater benefits than probiotics alone.
Participants:
Took the assigned intervention(s) for 4 weeks
Provided stool samples for gut microbiota analysis
Completed assessments of GI symptoms and behavior using validated questionnaires
Conditions
- Autism Spectrum Disorder
- Functional Gastrointestinal Disorders
Interventions
- DIETARY_SUPPLEMENT
-
Probiotic
A probiotic supplement in capsule form containing 4 strains of microorganisms, with a total of 10 × 10⁹ CFU (colony-forming units) per capsule. The strain composition per capsule was: Lactobacillus acidophilus L1 - 2.9 × 10⁹ CFU, Bifidobacterium longum LBL-01 - 2.9 × 10⁹ CFU, Lactobacillus rhamnosus - 2.9 × 10⁹ CFU, Saccharomyces boulardii - 1.3 × 10⁹ CFU. Each participant in this arm took one capsule per day in the morning on a full stomach, for a duration of 4 weeks. No other dietary interventions were applied to this group. This probiotic supplement was chosen because the strains in its content are among the most frequently researched and known strains in terms of intestinal health. Additionally, it does not contain FOS or inulin due to FODMAP restriction. .
- OTHER
-
Low-FODMAP Diet
A structured low-FODMAP diet intervention designed to restrict intake of fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. The diet was individualized and monitored by a registered dietitian over a 4-week period to ensure adherence and nutritional adequacy.
Sponsors & Collaborators
-
Istanbul Saglik Bilimleri University
collaborator OTHER -
Marmara University Pendik Training and Research Hospital
lead OTHER
Principal Investigators
-
Pınar Polat, PhD · Marmara University Pendik Training and Research Hospital
-
Neşe Perdahlı Fiş, Prof Dr · Marmara University Pendik Training and Research Hospital
-
Özlem Aytekin, AProf Dr · Saglik Bilimleri Universitesi
-
Fatih Özbey, Prof Dr · Saglik Bilimleri Universitesi
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-01
- Primary Completion
- 2024-03-01
- Completion
- 2024-03-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
NCT03514784 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Probiotics for Quality of Life in Autism Spectrum Disorders
NCT02903030 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prebiotic Intervention for Autism Spectrum Disorders
NCT02720900 ·Status: COMPLETED ·Phase: NA
-
Probiotics for Autism Spectrum Disorders: a Randomized Controlled Trial (The PASD Study)
NCT07345585 ·Status: RECRUITING ·Phase: NA
-
Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism
NCT02086110 ·Status: COMPLETED ·Phase: NA
-
Probiotic in Autism
NCT04939974 ·Status: UNKNOWN ·Phase: NA
-
Combined Human Milk Oligosaccharides (HMOs) and Probiotics Intervention for Children With Autism
NCT05151601 ·Status: UNKNOWN ·Phase: NA
-
Effect of Probiotic Compound K11T e K11TMax in ASD
NCT06382909 ·Status: COMPLETED ·Phase: NA
-
The Intervention of Lactobacillus Plantarum Probiotics in Adult Autistic Spectrum Disorders
NCT07118267 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of a Multispecies Probiotics on Autism Symptoms in Children
NCT06448767 ·Status: RECRUITING ·Phase: NA
-
Assessing the Impact of Probiotic Supplementation in Children Diagnosed With Autism Spectrum Disorder: the PROBI-O-TISM Study
NCT06906068 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms
NCT05603403 ·Status: COMPLETED ·Phase: PHASE4
-
Application of Probiotic PS128 in Children With ASD
NCT04942522 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children
NCT03539913 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement
NCT02353689 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Probiotic Consumption in Children With Autism Spectrum Disorder (ASD)
NCT06568588 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Psychophysiological Effects of Lactobacillus Plantarum PS128 in Preschool Children With Autism Spectrum Disorder
NCT03982290 ·Status: UNKNOWN ·Phase: NA
-
Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm
NCT02060084 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms
NCT05845073 ·Status: COMPLETED ·Phase: NA
-
Probiotic Mixture (L. Rhamnosus GG and L. Plantarum 299V) In Pediatric Irritable Bowel Syndrome
NCT07125625 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Open-label Pilot Study Synbiotic Treatment for Autism Spectrum Disorder
NCT06126185 ·Status: COMPLETED ·Phase: NA
-
Exploring the Gut-Brain-Behavior Axis With Biomarkers, Probiotic Efficacy, and Artificial Intelligence Algorithms
NCT06677840 ·Status: RECRUITING ·Phase: NA
-
Assessment of Efficiency and Safety of an Infant Formula Containing a Probiotic in Children
NCT01081067 ·Status: COMPLETED
-
Probiotic Therapy for Children and Adults With Autism Spectrum Disorder
NCT04655326 ·Status: COMPLETED ·Phase: NA
-
Effect of Probiotics on the Digestibility and Immunity in Infants
NCT02317406 ·Status: COMPLETED ·Phase: NA